Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares in the company, valued at $541,473.36. This represents a 14.62 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Teladoc Health Stock Down 1.9 %
Shares of NYSE TDOC traded down $0.17 during trading on Tuesday, hitting $8.65. 4,193,027 shares of the company traded hands, compared to its average volume of 6,044,048. The firm has a market capitalization of $1.50 billion, a price-to-earnings ratio of -1.50 and a beta of 1.27. The business's fifty day moving average is $10.40 and its 200 day moving average is $9.77. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $15.43.
Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Equities research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of analysts have recently commented on TDOC shares. Bank of America lifted their price target on Teladoc Health from $11.50 to $13.50 and gave the company a "neutral" rating in a research note on Wednesday, February 12th. Oppenheimer decreased their price target on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research report on Friday, January 24th. The Goldman Sachs Group dropped their price target on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating for the company in a research note on Monday, March 3rd. Piper Sandler reduced their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Finally, Royal Bank of Canada raised their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Eleven analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $11.26.
Check Out Our Latest Stock Report on TDOC
Institutional Trading of Teladoc Health
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Arizona State Retirement System increased its position in shares of Teladoc Health by 1.8% during the fourth quarter. Arizona State Retirement System now owns 49,691 shares of the health services provider's stock worth $452,000 after acquiring an additional 859 shares in the last quarter. Mercer Global Advisors Inc. ADV boosted its stake in Teladoc Health by 9.6% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 12,456 shares of the health services provider's stock valued at $113,000 after purchasing an additional 1,089 shares during the last quarter. Canada Pension Plan Investment Board increased its holdings in Teladoc Health by 0.5% during the 4th quarter. Canada Pension Plan Investment Board now owns 228,700 shares of the health services provider's stock worth $2,079,000 after purchasing an additional 1,200 shares in the last quarter. Summit Investment Advisors Inc. raised its stake in shares of Teladoc Health by 8.0% in the fourth quarter. Summit Investment Advisors Inc. now owns 18,009 shares of the health services provider's stock worth $164,000 after purchasing an additional 1,331 shares during the last quarter. Finally, Vise Technologies Inc. lifted its holdings in shares of Teladoc Health by 4.9% in the fourth quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider's stock valued at $274,000 after purchasing an additional 1,405 shares in the last quarter. Institutional investors own 76.82% of the company's stock.
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
